TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 04/19/22

The clinical-stage company TFF Pharmaceuticals (NASDAQ:TFFP) announced safety and pharmacokinetic (PK) results from its Phase 1 study of Niclosamide Inhalation Powder in COVID-19 on Tuesday. The company plans to use its Thin Film Freezing (TFF) technology to target the affected lungs with an ...

Niclosamide Inhalation Powder Well Tolerated with No Serious Adverse Events Across All Subject Cohorts Current Data Suggests Niclosamide Inhalation Powder is a Promising Antiviral Treatment to Combat COVID-19 FORT WORTH, Texas, April 19, 2022 (GLOBE NEWSWIRE) -- TFF Pharma...

Sunshine Biopharma (SBFM) +119% newly designed mRNA molecules prove effective against multidrug resistant cancer cells. System1 (SST) +26%. Recon Technology (RCON) +23%. Aterian (ATER) +13%. Guardforce AI (GFAI) +12% on expanding applications of robotics solutions. Arcus Biosci...

Image source: The Motley Fool. TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) Q4 2021 Earnings Call Mar 24, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: TFF Pharmaceuticals, Inc. (TFFP) Q4 2021 Earnings Call Transcript...

TFF Pharmaceuticals, Inc. (TFFP) Q4 2021 Earnings Conference Call March 24, 2022, 04:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President and CEO Dale Christensen - Director of Clinical Development Bill Williams - University of Texas, Austin Kirk Coleman - CFO...

TFF Pharmaceuticals press release (NASDAQ:TFFP): FY GAAP EPS of -$1.25 misses by $0.12. Revenue of $0.09M misses by $0.59M. As of December 31, 2021, TFF Pharmaceuticals reported cash and cash equivalents of $33.8 million. Shares +0.15%. For further details see: TFF P...

Pipeline Advancement Continues with Ongoing Phase 2 Studies for Voriconazole and Tacrolimus Programs Partnership Activity Surrounding Thin Film Freezing Continues to Expand Reflecting the Technology’s Broad Applicability Across Molecule Type and Therapeutic Area A...

The following slide deck was published by TFF Pharmaceuticals, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: TFF Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation

OTCQX:CCHWF, CIH, OTCQX:CWBHF, DRI, FDS, HOOK, OTCQX:JUSHF, KC, MOMO, NEOG, SNX, TFFP, TITN, TMDI For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Thursday's open

TFF Pharmaceuticals (NASDAQ:TFFP) is trading ~6% higher in the pre-market Thursday after announcing a research agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and The Geneva Foundation, a non-profit within the U.S. military. The Cooperative Research a...